Prosight Management, LP
Follow13F filer, CIK 1617201, DALLAS, TX
Prosight Management, LP reported $515,482,740 across 32 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 70.63% of the portfolio.
Accepted , ingested 13F-HR 0001420506-26-002713
- Period
- 2026-09-30
- Reported value
- $515M
- Holdings
- 32
- Top 10 weight
- 70.63%
- New
- 9
- Sold out
- 13
Part of the filer group Prosight Management, LP
Prosight Fund, LPProsight Partners, LLC
- Prosight Fund, LP
- Prosight Partners, LLC
- Prosight Plus Fund, LP
- W. Lawrence Hawkins
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ABVXadded | +269,400 | $26.7M |
| PRVAnew | +1,049,752 | $20.7M |
| STTKadded | +1,690,217 | $11.5M |
| DNLInew | +550,700 | $11.4M |
| PRAXnew | +36,400 | $10.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BSXreduced | -720,273 | -$31.4M |
| VEEVexited | -106,200 | -$18.8M |
| INSMreduced | -137,521 | -$15.7M |
| ALNYreduced | -61,080 | -$15.1M |
| JANXreduced | -861,281 | -$14.9M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001420506-26-002713, largest first. % of portfolio is the value over $515,482,740, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| LKFTLAKEFRONT BIOTHERAPEUTICS NV | 1,998,400 | $59.3M | 11.49% | -44,944 | Timeline | ||
| STTKSHATTUCK LABS INC | 7,648,094 | $52.2M | 10.12% | +1,690,217 | Timeline | ||
| JANXJANUX THERAPEUTICS INC | 2,943,200 | $50.9M | 9.87% | -861,281 | 2026-11-10, 13G/A: 3,150,450 shares, 5.15% of the class, 13G/A filed 2026-11-13 | Timeline | |
| NKTRNEKTAR THERAPEUTICS | 785,000 | $47.5M | 9.22% | -25,000 | Timeline | ||
| ABVXABIVAX SA | 376,794 | $37.3M | 7.24% | +269,400 | Timeline | ||
| INSMINSMED INC | 238,088 | $27.2M | 5.27% | -137,521 | Timeline | ||
| BSXBOSTON SCIENTIFIC CORP | 550,000 | $24M | 4.66% | -720,273 | Timeline | ||
| IRTCIRHYTHM HOLDINGS INC | 200,980 | $22.8M | 4.43% | +35,480 | Timeline | ||
| ALKSALKERMES PLC | 550,000 | $22.3M | 4.32% | +155,611 | Timeline | ||
| PRVAPRIVIA HEALTH GROUP INC | 1,049,752 | $20.7M | 4.01% | new | Timeline | ||
| MLYSMINERALYS THERAPEUTICS INC | 800,000 | $20.1M | 3.9% | +350,205 | Timeline | ||
| ZYMEZYMEWORKS INC | 721,100 | $19.1M | 3.71% | +46,666 | Timeline | ||
| SNDXSYNDAX PHARMACEUTICALS INC | 812,582 | $15.3M | 2.96% | -387,418 | Timeline | ||
| KURAKURA ONCOLOGY INC | 1,275,000 | $13.7M | 2.65% | -746,964 | Timeline | ||
| DNLIDENALI THERAPEUTICS INC | 550,700 | $11.4M | 2.21% | new | Timeline | ||
| PRAXPRAXIS PRECISION MEDICINES I | 36,400 | $10.6M | 2.06% | new | Timeline | ||
| HQYHEALTHEQUITY INC | 115,796 | $10.2M | 1.99% | new | Timeline | ||
| BBIOBRIDGEBIO PHARMA INC | 150,000 | $9.87M | 1.91% | new | Timeline | ||
| ALNYALNYLAM PHARMACEUTICALS INC | 37,000 | $9.13M | 1.77% | -61,080 | Timeline | ||
| HUMHUMANA INC | 22,000 | $8.39M | 1.63% | new | Timeline | ||
| ENOVENOVIS CORPORATION | 267,432 | $4.89M | 0.95% | new | Timeline | ||
| OKURONKURE THERAPEUTICS INC | 1,325,570 | $3.61M | 0.7% | +346,578 | Timeline | ||
| QTRXQUANTERIX CORP | 825,000 | $3.06M | 0.59% | new | Timeline | ||
| GENBGENERATE BIOMEDICINES INC | 144,756 | $2.17M | 0.42% | new | Timeline | ||
| ANTXAN2 THERAPEUTICS INC | 350,877 | $1.87M | 0.36% | -123,761 | Timeline | ||
| PLRXPLIANT THERAPEUTICS INC | 1,604,466 | $1.73M | 0.34% | +234,233 | Timeline | ||
| RCKTROCKET PHARMACEUTICALS INC | 595,024 | $1.56M | 0.3% | -104,976 | Timeline | ||
| RNTXREIN THERAPEUTICS INC | 1,660,197 | $1.33M | 0.26% | +560,197 | Timeline | ||
| COYACOYA THERAPEUTICS INC | 229,600 | $1.15M | 0.22% | +59,600 | Timeline | ||
| CRBPCORBUS PHARMACEUTICALS HLDGS | 168,383 | $1.15M | 0.22% | -481,617 | Timeline | ||
| IMRXIMMUNEERING CORP | 150,000 | $614K | 0.12% | +113,139 | Timeline | ||
| ADCTADC THERAPEUTICS SA | 399,900 | $488K | 0.09% | -7,424,849 | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| VEEVVEEVA SYS INC | 106,200 | $18.8M | shares |
| CRNXCRINETICS PHARMACEUTICALS IN | 374,666 | $14M | shares |
| ICUIICU MED INC | 51,000 | $7.48M | shares |
| ISRGINTUITIVE SURGICAL INC | 17,000 | $6.76M | shares |
| PRCTPROCEPT BIOROBOTICS CORP | 268,269 | $6.06M | shares |
| WGSGENEDX HOLDINGS CORP | 85,500 | $5.87M | shares |
| OPCHOPTION CARE HEALTH INC | 270,716 | $5.68M | shares |
| EBSEMERGENT BIOSOLUTIONS INC | 459,952 | $3.85M | shares |
| PFEPFIZER INC | 135,366 | $3.26M | shares |
| KIDSORTHOPEDIATRICS CORP | 157,500 | $3.01M | shares |
| TECXTECTONIC THERAPEUTIC INC | 39,731 | $1.37M | shares |
| MGTXMEIRAGTX HLDGS PLC | 90,000 | $1.22M | shares |
| EFOREVERFORTH INC | 67,500 | $1.21M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001420506-26-002713 | base | 2026-11-13 |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13G/A 0001617201-26-000008 | JANX | 2026-11-13 | ||
| 13G/A 0001617201-26-000007 | ADCT | 2026-11-13 | ||
| 13F-HR 0001420506-26-002713 | Quarter ended 2026-09-30 | 2026-11-13 | ||
| 13F-HR 0001420506-26-001799 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-26-001036 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-26-000422 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-003233 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-002021 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-001167 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-000459 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-24-002447 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-24-001439 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-24-000996 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-24-000355 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-23-002059 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-23-001664 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-23-001564 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-23-001021 | Quarter ended 2023-03-31 | 2023-05-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-23-000529 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-22-002133 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-22-001583 | Quarter ended 2022-06-30 | 2022-08-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-22-001078 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-22-000326 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-21-001557 | Quarter ended 2021-09-30 | 2021-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-21-001140 | Quarter ended 2021-06-30 | 2021-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-21-000690 | Quarter ended 2021-03-31 | 2021-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-21-000234 | Quarter ended 2020-12-31 | 2021-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-20-001278 | Quarter ended 2020-09-30 | 2020-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-20-000916 | Quarter ended 2020-06-30 | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-20-000606 | Quarter ended 2020-03-31 | 2020-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-20-000263 | Quarter ended 2019-12-31 | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-19-001121 | Quarter ended 2019-09-30 | 2019-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-19-000842 | Quarter ended 2019-06-30 | 2019-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-19-000514 | Quarter ended 2019-03-31 | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-19-000229 | Quarter ended 2018-12-31 | 2019-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-18-001022 | Quarter ended 2018-09-30 | 2018-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-18-000778 | Quarter ended 2018-06-30 | 2018-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-18-000462 | Quarter ended 2018-03-31 | 2018-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-18-000189 | Quarter ended 2017-12-31 | 2018-02-13 | acceptance time not in the bulk data set |